tirzepatide vision TGA issues warning over GLP-1-based drugs' potential to cause rare eye disorder Vision loss risks in patients

Johns Hopkins Medicine: The Pros, Cons, and Unknowns of Popular Weight Loss Drugs National Association of Insurance Commissioners: Does Insurance Cover Prescription Weight Loss Injectables

one 68-week, randomized, double-blind, placebo withdrawal trial

Andreea Ciudin 4-7

The Promise and Caution of Retatrutide: Understanding Research-Grade Medications for Patients Dr

While off-label prescribing is legal, it has led to widespread use without the same level of long-term safety data that would accompany a formal weight-loss approval

While lower doses of semaglutide are available under other brand names, such as Ozempic (primarily used for managing type 2 diabetes), only the higher-dose Wegovy formulation is FDA-approved for weight management purposes